Dr. William Clark elected as World Apheresis Association President, 2016–2018

Abstract

Dr. Bill Clark – the newly elected President of the World Apheresis Association Board of Directors – is a Professor of Medicine at Western University Canada, a Scientist at the Lawson Health Research Institute and a Director of Apheresis and Consulting Nephrologist at the London Health Sciences Centre. Dr. Clark is a graduate of Western University Canada and he obtained his fellowship training in Internal Medicine and Nephrology at the University of Toronto, Western University Canada, Guys and Kings College Hospital UK. He obtained post fellowship training at the University of London and London School of Economics UK and Faculty of Epidemiology at McGill University. Dr. Clark is a clinician scientist in the Program of Experimental Medicine whose research has been directed at interventions that prevent progressive renal disease and are based on in vitro and in vivo animal and human experimentation as well as observational studies and randomized controlled trials. He is author of more than 382 scholarly publications, a Professor of Medicine and former Chairman of the Division of Nephrology at Western University Canada who also serves on the Boards of the World Apheresis Association (President 2016) and the Canadian Apheresis Group and is Scientific Co-Chair, Biomedical Research Council of the Kidney Foundation of Canada and a member of the Canadian Society of Nephrology Scientific Committee. Dr. Clark is the 2012 recipient of the National Medal of Research Excellence of the Kidney Foundation of Canada and the Queen Elizabeth II Diamond Jubilee Medal, in 2014 he was elected Fellow of the Canadian Academy of Health Sciences, and also the recipient of the HaroldW. Ashenmil National Award from the Kidney Foundation of Canada in recognition of his leadership and development and in 2016 he is the recipient of Lawson Health Research Institute Career Scientist award. Dr Clark’s areas of expertise include: Epidemiology, thrombotic microangiopathies, aphaeresis, observational studies, Randomized Controlled Clinical Trials, Cost Benefit Analysis, Interventions/Renal Disease, autoimmune diseases, Lupus Nephritis, Systemic Vasculitis.